Showing results (61-70 of 335) with videos related to

Sort By:
Pageof 34
Journal of Pharmaceutical and Biomedical Analysis|January 13, 2023
Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MSSimon P de Leeuw, Peter de Bruijn, Stijn L W Koolen, et al.
BMC Cancer|April 9, 2015
Oromandibular dystonia: a serious side effect of capecitabineMelanie J M van Pelt-Sprangers, Eric C T Geijteman, Jelmer Alsma, et al.
British Journal of Cancer|November 26, 2024
Effects of tamoxifen on cognitive function in patients with primary breast cancerMaryse J Luijendijk, Sanne M Buijs, Agnes Jager, et al.
Breast Cancer Research and Treatment|June 14, 2013
Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifenLisette Binkhorst, Ron H J Mathijssen, Myrthe P P van Herk-Sukel, et al.
Acta Oncologica (Stockholm, Sweden)|March 10, 2018
Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group databaseStefan Sleijfer, Elisa Rizzo, Saskia Litière, et al.
Clinical Pharmacokinetics|July 28, 2016
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib ExposureSander Bins, Karel Eechoute, Jacqueline S L Kloth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic studyFrederike K Engels, Walter J Loos, Jessica M van der Bol, et al.
British Journal of Clinical Pharmacology|April 5, 2014
Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifenRob ter Heine, Lisette Binkhorst, Anne Joy M de Graan, et al.
Clinical Pharmacokinetics|August 19, 2016
Development of a Pharmacokinetic Model to Describe the Complex Pharmacokinetics of Pazopanib in Cancer PatientsHuixin Yu, Nielka van Erp, Sander Bins, et al.
American Journal of Physiology. Renal Physiology|July 2, 2025
Mechanisms of anti-VEGF therapy-induced kidney injury: current insights and future perspectives in combination with immune checkpoint inhibitorsTom J J Uyl, Abigail Ngo, Delaney Pratt, et al.
Pageof 34